Maverick Capital’s Celgene Corp CELG Stock Holding History

Maverick Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-19,150	Closed	-$2.49M	–	238
2017 Q2	$2.49M	Buy	+19,150	New	+$2.35M	0.03%	108
2016 Q2	–	Sell	-4,900	Closed	-$490K	–	162
2016 Q1	$490K	Buy	4,900 +2,520	+106%	+$259K	0.01%	120
2015 Q4	$285K	Buy	2,380 +290	+14%	+$33.6K	﹤0.01%	92
2015 Q3	$226K	Sell	2,090 -140	-6%	-$17.4K	﹤0.01%	114
2015 Q2	$258K	Hold	2,230	–	–	﹤0.01%	91
2015 Q1	$257K	Buy	+2,230	New	+$266K	﹤0.01%	93

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Maverick Capital's CELG Position: Q3 2017 in Review

Maverick Capital sold out of Celgene Corp (CELG) in Q3 2017, closing a stake of 19,150 shares — an estimated $2.49M sold.

Maverick Capital first reported a position in CELG in Q1 2015 and held it in 6 quarters. The position peaked at $2.49M in Q2 2017. 1,484 funds tracked by Wall St. Rank hold CELG as of Q3 2017.

Maverick Capital reported no remaining Celgene Corp position as of Q3 2017 after selling out during the quarter.
Maverick Capital sold 19,150 Celgene Corp shares in Q3 2017, an estimated $2.49M.
Maverick Capital first reported a position in Celgene Corp in Q1 2015 and held it in 6 quarters.
Maverick Capital's Celgene Corp position peaked at $2.49M in Q2 2017.
1,484 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2017.

Based on Maverick Capital's 13F filing for Q3 2017, filed 14 Nov 2017.